Pascal and Francis Bibliographic Databases


Search results

Your search


Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV


A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 776

  • Page / 32

Selection :

  • and

A bayesian population PK-PD model of ispinesib-induced myelosuppressionKATHMAN, S. J; WILLIAMS, D. H; HODGE, J. P et al.Clinical pharmacology and therapeutics. 2007, Vol 81, Num 1, pp 88-94, issn 0009-9236, 7 p.Article

Conditioning the leukemic patient before allogeneic BMT : value of intensifying immunosuppression in the context of different levels of T lymphocyte depletion of the graftMIRALBELL, R; CHAPUIS, B; NOUET, P et al.Bone marrow transplantation (Basingstoke). 1993, Vol 11, Num 6, pp 447-451, issn 0268-3369Article

Chemotherapy-induced myelosuppressionMAXWELL, M. B; MAHER, K. E.Seminars in oncology nursing. 1992, Vol 8, Num 2, pp 113-123, issn 0749-2081Article

Who should receive myeloablative therapy for lymphoma?LISTER, T. Andrew.The New England journal of medicine. 2004, Vol 350, Num 13, pp 1277-1278, issn 0028-4793, 2 p.Article

Unexpected prolonged myelosuppression after mitomycin, mitoxantrone and methotrexateMUHONEN, T. T; WIKLUND, T. A; BLOMQVIST, C. P et al.European journal of cancer. Part A. 1992, Vol 28, Num 12, pp 1974-1976Article

The use of ranitidine in bone marrow transplantation: a review of 223 casesAGURA, E. D; VILA, E; PETERSEN, F. B et al.Transplantation. 1988, Vol 46, Num 1, pp 53-56, issn 0041-1337Article

Allogeneic hematopoietic SCT and mechanical heart valve: feasibility of reduced toxicity myeloablative conditioningPREBET, T; DEVILLIER, R; FURST, S et al.Bone marrow transplantation (Basingstoke). 2010, Vol 45, Num 10, pp 1574-1575, issn 0268-3369, 2 p.Article

Le risque de neutropénieLa Revue du praticien (Paris). 2006, Vol 56, Num 18, pp 2042-2042, issn 0035-2640, 1 p.Article

Granulocyte colony-stimulating factor : effective in ameliorating fluorouracil-based myelosuppression ?CHRISTMAN, K; SALTZ, L; SCHWARTZ, G et al.Journal of the National Cancer Institute. 1993, Vol 85, Num 10, pp 826-827, issn 0027-8874Article

Reliability of a pretransplant i.v. BU test dose performed 2 weeks before myeloablative FluBu conditioning regimenBERI, R; CHUNDURI, S; RONDELLI, D et al.Bone marrow transplantation (Basingstoke). 2010, Vol 45, Num 2, pp 249-253, issn 0268-3369, 5 p.Article

The evolution of hematopoietic SCT in myelodysplastic syndromeKINDWALL-KELLER, T; ISOLA, L. M.Bone marrow transplantation (Basingstoke). 2009, Vol 43, Num 8, pp 597-609, issn 0268-3369, 13 p.Article

Mechanism of flt3 ligand expression in bone marrow failure : Translocation from intracellular stores to the surface of T lymphocytes after chemotherapy-induced suppression of hematopoiesisCHKLOVSKAIA, E; JANSEN, W; NISSEN, C et al.Blood. 1999, Vol 93, Num 8, pp 2595-2604, issn 0006-4971Article

Effect of conagenin on thrombocytopenia induced by antitumor agents in miceKAWATSU, M; YAMASHITA, T; ISHIZUKA, M et al.Journal of antibiotics (Tokyo. 1968). 1994, Vol 47, Num 10, pp 1123-1129, issn 0021-8820Article

Severe myelosuppression resulting from concurrent administration of granulocyte colony-stimulating factor and cytotoxic chemotherapyMEROPOL, N. J; MILLER, L. L; KORN, E. L et al.Journal of the National Cancer Institute. 1992, Vol 84, Num 15, pp 1201-1203, issn 0027-8874Article

Oral toxicity of chemotherapeutic agentsPETERSON, D. E.Seminars in oncology. 1992, Vol 19, Num 5, pp 478-491, issn 0093-7754Article

Extremely prolonged continuous intraperitoneal infusion of cytosine arabinosideKIRMANI, S; ZIMM, S; CLEARY, S. M et al.Cancer chemotherapy and pharmacology. 1990, Vol 25, Num 6, pp 454-458, issn 0344-5704Article

Current status of haploidentical stem cell transplantationDEY, Bimalangshu R; SPITZER, Thomas R.British journal of haematology. 2006, Vol 135, Num 4, pp 423-437, issn 0007-1048, 15 p.Article

Circumvention of chemotherapy-induced myelosuppression by transfer of the mdr1 geneBOESEN, J. J. B; NOOTER, K; VALERIO, D et al.Biotherapy (Dordrecht). 1993, Vol 6, Num 4, pp 291-302, issn 0921-299XArticle

Polyclonal hematopoiesis in interferon-induced cytogenetic remissions of chronic myelogenous leukemiaCLAXTON, D; DEISSEROTH, A; TALPAZ, M et al.Blood. 1992, Vol 79, Num 4, pp 997-1002, issn 0006-4971Article

Complications of intravesical chemotherapyBRANTLEY THRASHER, J; DAVID CRAWFORD, E.Urologic clinics of North America. 1992, Vol 19, Num 3, pp 529-539, issn 0094-0143Article

Mutated recombinant human heavy-chain ferritins and myelosuppression in vitro and in vivo : a link between ferritin ferroxidase activity and biological functionBROXMEYER, H. E; COOPER, S; LEVI, S et al.Proceedings of the National Academy of Sciences of the United States of America. 1991, Vol 88, Num 3, pp 770-774, issn 0027-8424, 5 p.Article

Myelosuppression and kinase selectivity of multikinase angiogenesis inhibitorsKUMAR, R; CROUTHAMEL, M.-C; ROMINGER, D. H et al.British journal of cancer. 2009, Vol 101, Num 10, pp 1717-1723, issn 0007-0920, 7 p.Article

A single dose of thrombopoietin shortly after myelosuppressive total body irradiation prevents pancytopenia in mice by promoting short-term multilineage spleen-repopulating cells at the transient expense of bone marrow-repopulating cellsNEELIS, K. J; VISSER, T. P; DIMJATI, W et al.Blood. 1998, Vol 92, Num 5, pp 1586-1597, issn 0006-4971Article

Répercussions immunohématologiques de traitements antinéoplasiquesTICHELLI, A.Médecine et hygiène. 1992, Vol 50, Num 1932, pp 1338-1342, issn 0025-6749, 3 p.Article

In vitro myelosuppressive effects of the parvovirus minute virus of mice (MVMi) on hematopoietic stem and committed progenitor cellsSEGOVIA, J. C; REAL, A; BUEREN, J. A et al.Blood. 1991, Vol 77, Num 5, pp 980-988, issn 0006-4971Article

  • Page / 32